Corcept Therapeutics Insider Sold Shares Worth $1,160,731, According to a Recent SEC Filing

MT newswire2026/10/06 07:26

03:26 AM EDT, 10/06/2026 (MT Newswires) -- Joseph Douglas Lyon, Chief Accounting & Technology Officer, on October 01, 2026, sold 10,000 shares in Corcept Therapeutics (CORT) for $1,160,731. Following the Form 4 filing with the SEC, Lyon has control over a total of 5,683 common shares of the company, with 5,683 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1088856/000119312526414684/xslF345X05/ownership.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.